Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.
Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available.We conducted a prospective observational study including 11 kidney...
Main Authors: | Marie Matignon, Caroline Pilon, Morgane Commereuc, Cynthia Grondin, Claire Leibler, Tomek Kofman, Vincent Audard, José Cohen, Florence Canoui-Poitrine, Philippe Grimbert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5487035?pdf=render |
Similar Items
-
Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
by: Caroline Pilon, et al.
Published: (2020-01-01) -
dsa
by: a
Published: (2010-01-01) -
Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response
by: Caroline Pilon, et al.
Published: (2019-12-01) -
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
by: Claire Leibler, et al.
Published: (2018-11-01) -
Leisure and Productivity in Older Adults with Cancer: A Systematic Review
by: Cynthia Engels, et al.
Published: (2021-01-01)